Our mission
Founded in 2014 with a single conviction: that dependable medicine should reach everyone, everywhere.
We develop, manufacture, and deliver high-quality pharmaceuticals and in-vitro diagnostic products — so more people, in more places, can count on the care they need.
Access
Affordable, dependable supply built for regulated and emerging markets alike.
Quality
One quality system, applied to every batch, slide, and result we produce.
Our history
From a single line to a dependable network.
2014
Mynarix is founded to make dependable generics accessible across underserved markets.
2018
First WHO-GMP accreditation; portfolio expands into respiratory and cardiology.
2022
Diagnostics division launches, adding in-vitro reagents and laboratory systems.
2026
Sterile manufacturing capacity expands; portfolio reaches 120+ products across 30+ markets.
Quality & certifications
Held to the standards care depends on.
Our quality management system governs sourcing, manufacturing, testing, and release. Every facility operates to current good manufacturing practice, with independent audits and full batch traceability.
Batch traceability
Every lot traceable from raw material to release.
Independent audits
Regular third-party and regulatory inspections.
Pharmacovigilance
Continuous safety monitoring across the portfolio.
Cold-chain integrity
Validated storage and distribution controls.